PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC12474311::ACT027044

NY-ESO-1 157-165 epitope

Evidence text

Paper-level observation

TCR-T cells showed the greatest functional avidity for T2 cells, with an EC50 of 0.004 μM (Section 3.3, Figure 3a).
textConfidence: medium

Assay observation

Activity
Immunomodulatory
Subtype
T-cell activation
Measure
EC50
Comparator
=
Raw observation
0.004 μM
Normalized measurement
=0.004 µM
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
T2
Assay method
Not reported by source
Sequence
SLLMWITQC
Standardization
ready simple

Source publication

TCR-T Cell Recognition of an NY-ESO-1 Epitope Presented by HLA-A2 Supertype: Implications for Cancer Immunotherapy

Vaccines · 2025

DOI 10.3390/vaccines13090898 PMC12474311
Parent mention

Related peptide identities

PEPDIA-PLP-002699

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.